companies developing glp 1 drugs seek a second obesity treatment revolution—in pill form | Science The Disruptive Power of Weight

*adapted from American Diabetes Association 2024 Standards of Care in Diabetes Available GLP-1 Receptor Agonists (GLP-1 RA) The Table below compares currently available GLP-1RA formulations, notes on their dosing and administration schedule, adjustments and demonstrated cardiorenal benefits

As the bodys master antioxidant, glutathione is vital for maintaining a youthful, healthy appearance

The current once-weekly subcutaneous injection model works, but once-monthly or even implantable formulations are on the horizon

Across this body of research, no significant toxicity has been reported at doses ranging from 1 g/kg to 10 mg/kg in rodent models